Request Trial
Sklo Studio / Shutterstock.com
3 February 2026NewsEuropeMarisa Woutersen

Drowning in EU regulations? Five tips for surviving the deluge of new rules

As legislative activity in life sciences increases, in-house teams are struggling to keep up. Experts share their sources and strategies for monitoring developments, coordinating internally, and knowing when to engage.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
European court backs AstraZeneca unit in blood cancer combo dispute
28 May 2026   A European court dismissed a challenge by a German generics manufacturer, confirming the validity of a patent covering a blood cancer combination therapy.
Europe
Chinese medtech company fined by UPC over injunction breaches
21 May 2026   The court has imposed a financial penalty after finding it continued promoting banned devices online despite an injunction covering five European countries.
Europe
Orrick lands five-member M&A team in Paris
18 May 2026   A high-profile Paris-based partner and four others join the firm, bringing experience across M&A, venture capital and life sciences-focused transactions.


Editor's picks

Takeda to appeal $885m jury verdict over ‘pay-for-delay’ scheme
Americas
Takeda to appeal $885m jury verdict over ‘pay-for-delay’ scheme
19 May 2026

Editor's picks

Americas
Takeda to appeal $885m jury verdict over ‘pay-for-delay’ scheme
19 May 2026
Americas
From the courtroom: Hikma v Amarin SCOTUS oral arguments
30 April 2026
Americas
Penile implant maker’s $17m trade secret award unravels
20 April 2026
Biotechnology
Closing the women's health gap offers ‘benefits for all’
7 April 2026
Europe
European patent offices raise fees
2 April 2026
Americas
Argentina’s patent reset: Why pharma can no longer ignore Latin America's second-largest market
1 April 2026

More features

Federal Circuit tosses $59m trade secrets judgment against EOFlow
Neal Gerber Eisenberg expands in Chicago with new litigator
European court backs AstraZeneca unit in blood cancer combo dispute
Takeda’s China IP head: What pharma is still getting wrong
Boehringer Ingelheim adds ex-Teva executive to patent team
AI, anxiety, and antibodies: The issues dominating life sciences
UPC judge: ‘Expectations of you as a woman are the challenge’
How should in-house teams adopt AI? ‘Carefully’, says secrets expert